In reaction to strong earnings/guidance:

BGP +14.9% (also said it is exploring strategic alternatives), IDMI +13.4%, PLCE +12.2%, IHS +4.4%, NKE +4.0%, PRGS +3.9%, MLHR +3.9%, HUM +3.3%, SCVL +3.0%, GES +1.7%, CRAI +1.1%, IPCM +1.0%... Select financial stocks modestly rebounding: NCC +5.5%, CFC +3.9%, ING +1.0%... Other news: XTLB +15.5% (signs $108 mln deal for the licensing of its pre- clinical program in Hepatitis C to Presidio Pharmaceuticals), SSRX +4.9% (approves share repurchase program of up to $20 mln), HOKU +4.1% (announces signing of polysilicon reactor supply contract for potential expansion), BSC +3.4% (JPMorgan moves to woo top Bear staff - FT), UN +3.1% (still checking), OSG +1.3% (FRO discloses 5.2% stake in 13D filing; sees the investment in OSG as a good value)... Analyst upgrades: FNM +5.3% (upgraded to Outperform at Keefe Bruyette), FRE +5.2% (upgraded to Outperform at Keefe Bruyette), RCII +3.4% (upgraded to Buy at Stifel), NFLX +4.7% (upgraded to Buy at Cantor), AUO +2.3% (initiated with Buy at Jefferies), TTEC +2.2% (upgraded to Outperform at Wachovia), GE +2.0% (upgraded to Buy at Merrill), DTV +1.8% (initiated with Buy at tier 1 firm), ATHR +1.7% (upgraded to Buy at ThinkEquity), RTIX +1.6% (initiated with Buy at Pacific Growth), X +1.5% (upgraded to Buy at Goldman).